Yes, there are medications like GLP-1 receptor agonists that can increase GLP-1 activity and are used to treat type 2 diabetes
Unlike the injectables, it requires daily dosing with strict timing instructions
The interaction between DNA methylation and histone modifications, two major epigenetic mechanisms, also has adverse effects on child health outcomes
Unlike recombinant GH therapy, sermorelin has not been strongly associated with severe fluid retention, insulin resistance, or joint pain in the short term, though long-term data are limited
Regulatory environment (external): Active uncertainty - FDA's April 2026 proposal to restrict 503B compounding remains open for public comment through June 29, 2026
Peer review Peer review information Nature Reviews Drug Discovery thanks the anonymous reviewers for their contribution to the peer review of this work